Profile of Microbial Keratitis after Corneal Collagen Cross-Linking

Table 1

Clinical profile of patients who developed keratitis after collagen cross-linking.

Clinical profile; (Age/Sex)	Associated conditions and treatment for the same  duration		Preoperative BCVA	Procedure	Day of presentation of symptoms from day of surgery	Treatment	Time for resolution of symptoms	Rehabilitation	Final BCVA
Patient 1; (27/F)	Bronchial asthma; (12 years)	Oral/Inhalational steroids; (12 years)	20/30	Conventional CXL	3	Fortified antibiotics	6 weeks	FEK	20/20
Patient 2; (18/M)	Vernal catarrh; (10 years)	Topical steroids; (10 years)	20/20	Conventional CXL	3	Fortified antibiotics	4 weeks	RGP	20/30
Patient 3; (25/M)	Eczema; (5 years)	Oral cyclophosphamide; (5 years)	20/20	Conventional CXL	3	Fortified antibiotics	5 weeks	Advised PKP	20/120
Patient 4; (16/M)	Vernal catarrh; (6 years)	Topical steroids; (6 years)	20/20	Conventional CXL	3	Fortified antibiotics	5 weeks	AMG, under follow-up	20/200

M: male, F: female, BCVA: best corrected visual acuity, FEK: femtosecond enabled penetrating keratoplasty, PKP: penetrating keratoplasty, RGP: rigid gas permeable lens, and AMG: amniotic membrane grafting.